Reply to Woodie et al, "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX".

Torres T, Blauvelt A, Strober B, van de Kerkhof P, Eakin GS, Winthrop K, Gelfand JM

Open source

DOI
10.1016/j.jaad.2025.12.129
Published
2026 Jul
Container
Journal of the American Academy of Dermatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaad.2025.12.129,
  title = {Reply to Woodie et al, "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX".},
  author = {Torres T and Blauvelt A and Strober B and van de Kerkhof P and Eakin GS and Winthrop K and Gelfand JM},
  year = {2026},
  journal = {Journal of the American Academy of Dermatology},
  doi = {10.1016/j.jaad.2025.12.129},
  url = {https://doi.org/10.1016/j.jaad.2025.12.129}
}

RIS

TY  - JOUR
TI  - Reply to Woodie et al, "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX".
AU  - Torres T
AU  - Blauvelt A
AU  - Strober B
AU  - van de Kerkhof P
AU  - Eakin GS
AU  - Winthrop K
AU  - Gelfand JM
PY  - 2026
JO  - Journal of the American Academy of Dermatology
DO  - 10.1016/j.jaad.2025.12.129
UR  - https://doi.org/10.1016/j.jaad.2025.12.129
ER  - 

APA

T, T., A, B., B, S., P, V. D. K., GS, E., K, W., & JM, G. (2026). Reply to Woodie et al, "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX".. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2025.12.129

Source records